Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial | Zendy

Anthony Raymond Tam | Zendy; Ruiqi Zhang | Zendy; Kwok-Cheung Lung | Zendy; Raymond Liu | Zendy; Ka-Yi Leung | Zendy; Danlei Liu | Zendy; Yujing Fan | Zendy; Lu Lu | Zendy; Athene Hoi-Ying Lam | Zendy; Tom WaiHin Chung | Zendy; Cyril ChikYan Yip | Zendy; Jenny Lo | Zendy; Alan Wu | Zendy; Rodney Lee | Zendy; Wai Ching Sin | Zendy; Pauline Yeung Ng | Zendy; Wai Ming Chan | Zendy; HoiPing Shum | Zendy; WingWa Yan | Zendy; Jasper FukWoo Chan | Zendy; Vincent ChiChung Cheng | Zendy; Chak Sing Lau | Zendy; Kelvin KaiWang To | Zendy; KwokHung Chan | Zendy; Kwok-Yung Yuen | Zendy; Ivan Fan-Ngai Hung | Zendy

Open Access

Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial

Author(s) -

Anthony Raymond Tam,

Ruiqi Zhang,

Kwok-Cheung Lung,

Raymond Liu,

Ka-Yi Leung,

Danlei Liu,

Yujing Fan,

Lu Lu,

Athene Hoi-Ying Lam,

Tom WaiHin Chung,

Cyril ChikYan Yip,

Jenny Lo,

Alan Wu,

Rodney Lee,

Wai Ching Sin,

Pauline Yeung Ng,

Wai Ming Chan,

HoiPing Shum,

WingWa Yan,

Jasper FukWoo Chan,

Vincent ChiChung Cheng,

Chak Sing Lau,

Kelvin KaiWang To,

KwokHung Chan,

Kwok-Yung Yuen,

Ivan Fan-Ngai Hung

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac523

Subject(s) - medicine , clinical endpoint , regimen , hazard ratio , confidence interval , randomized controlled trial , adverse effect , viral load , gastroenterology , immunology , virus

Early antiviral therapy was effective in the treatment of coronavirus disease 2019 (COVID-19). We assessed the efficacy and safety of combined interferon beta-1b and remdesivir treatment in hospitalized COVID-19 patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research